Inconsistencies in regulation hinders efforts to combat deadly diseases with GM technology
The full potential of genetic modification or GM technology to tackle some of the world’s most dangerous diseases is still not being realised well over a decade after it was first developed. The lack of effective international regulation, regional variations in public opinion and uncertainties about the long-term effects are all hindering progress, say scientists from The Pirbright Institute, in a new discussion paper.